INTERNATIONAL MARKETS FOR VASCULAR ACCESS SITE CLOSURE DEVICES

99 Pages | 38 Exhibits | 2016 Analysis | Forecasts Through 2020

OVERVIEW:
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global vascular access site closure devices, or vascular closure devices (VCDs), market.

VASCULAR CLOSURE DEVICES MARKET HIGHLIGHTS

  • Cardiovascular diseases (CVDs) are the leading causes of death throughout the world. An estimated 17 million people die each year from CVDs. Global CVD-related procedures are expected to continue experiencing moderate growth as more people around the world gain access to improved healthcare.
  • The global market for VCDs is anticipated to experience annual growth in the high, single digits, exceeding $1.3 billion by 2020.
  • The US is currently accounts for 40% of all VCD sales, followed by the five major European markets (France, Germany, Italy, Spain, and the UK), Japan.
  • The largest growth is expected to occur in the RoW region, which includes the Asia-Pacific market. By 2020, the RoW market for VCDs will surpass the five major European markets and account for approximately 30% of total VCD sales.


TABLE OF CONTENTS:
EXECUTIVE SUMMARY
 
i. Methodology 

Exhibit ES-1: Global Vascular Closure Devices Market, Share by Country/Region, 2015 and 2020 

1. CARDIOVASCULAR/PERIPHERAL VASCULAR DISEASE OVERVIEW
 
1.1 Selected Cardiovascular Diseases/Disorders 
	1.1.1 Coronary Heart Disease 
		1.1.1.1 Atherosclerosis 
		1.1.1.2 Angina Pectoris 
		1.1.1.3 Myocardial Infarction 
	1.1.2 Hypertension 
	1.1.3 Cardiomyopathy 
	1.1.4 Congenital Heart Defects 
	1.1.5 Heart Failure 
1.2 Selected Peripheral Vascular Diseases/Disorders 
	1.2.1 Peripheral Artery Disease 
	1.2.2 Aneurysm 
	1.2.3 Deep Vein Thrombosis and Pulmonary Embolism 
	1.2.4 Chronic Venous Insufficiency 

Exhibit 1-1: Statistics for Selected Coronary Heart Disease Risk Factors 
Exhibit 1-2: Angina Pectoris, Selected Statistics 
Exhibit 1-3: Clinical Classification of AMI 
Exhibit 1-4: Myocardial Infarction, Selected Statistics 
Exhibit 1-5: Estimated Incidence Rates for Myocardial Infarction, Select Countries 
Exhibit 1-6: Hypertension, Selected Statistics 
Exhibit 1-7: Estimated Prevalence Rates for Hypertension, Select Countries 
Exhibit 1-8: Cardiomyopathy, Selected Statistics 
Exhibit 1-9: Congenital Heart Defects, Selected Statistics 
Exhibit 1-10: Summary, American College of Cardiology/American Heart Association Heart Failure Staging System 
Exhibit 1-11: Heart Failure, Selected Statistics 
Exhibit 1-12: Estimated Prevalence Rates for Chronic Heart Failure, Select Countries 
Exhibit 1-13: Peripheral Artery Disease, Selected Statistics 
Exhibit 1-14: Aortic Aneurysm, Selected Statistics 
Exhibit 1-15: Deep Vein Thrombosis, Selected Statistics 
Exhibit 1-16: Classification of Chronic Venous Insuffiency 
Exhibit 1-17: Chronic Venous Insufficiency, Selected Statistics 

2. VASCULAR ACCESS SITE CLOSURE DEVICES
 
2.1 Technologies 
2.2 Complications 
2.3 Products 

Exhibit 2-1: Collagen Plug-based Vascular Closure Devices/St. Jude Medical's Angio-Seal Evolution 
Exhibit 2-2: Gelfoam/Sealant-based Vascular Closure Devices/ Cordis's ExoSeal 
Exhibit 2-3: Selected Images of Hemostatic Patches 
Exhibit 2-4: Hybrid Vascular Closure Devices/Cardinal Health's MYNX ACE 
Exhibit 2-5: Staple/Clip-based Vascular Closure Devices/Abbott Vascular's Perclose ProGlide and StarClose SE 
Exhibit 2-6: Selected Images of External Hemostatic Devices 

3. GLOBAL MARKETS FOR VASCULAR ACCESS SITE MANAGEMENT DEVICES
 
3.1 Global Competitors 
3.2 Market Forecast: United States 
	3.2.1 Competitors 
3.3 Market Forecast: Europe 
	3.3.1 Competitors 
3.4 Market Forecast: Japan 
	3.4.1 Competitors 
3.5 Market Forecast: Rest of the World 
	3.5.1 Competitors 

Exhibit 3-1: Cardiovascular Disease Cases by Country/Region, Combined Caseloads, 2015-2020 
Exhibit 3-2: Global Vascular Closure Devices, Market Forecast, 2015-2020 
Exhibit 3-3: Global Vascular Closure Devices Sales by Country/Region, Combined Market Forecast, 2015-2020 
Exhibit 3-4: 2015, Global Vascular Closure Devices Market, Share by Country/Region 
Exhibit 3-5: 2015, Global Vascular Closure Devices Market, Share by Supplier 
Exhibit 3-6: United States Vascular Closure Devices, Market Forecast, 2015-2020 
Exhibit 3-7: 2015, United States Vascular Closure Devices Market, Share by Supplier 
Exhibit 3-8: 2013, Selected Healthcare Statistics for Select European Countries 
Exhibit 3-9: European Vascular Closure Devices, Market Forecast, 2015-2020 
Exhibit 3-10: 2015, European Vascular Closure Devices Market, Share by Supplier 
Exhibit 3-11: Japanese Vascular Closure Devices, Market Forecast, 2015-2020 
Exhibit 3-12: 2015, Japanese Vascular Closure Devices Market, Share by Supplier 
Exhibit 3-13: Rest of the World Vascular Closure Devices, Market Forecast, 2015-2020 
Exhibit 3-14: 2015, Rest of the World Vascular Closure Devices Market, Share by Supplier 

APPENDIX: COMPANY LISTING
 
APPENDIX: BIBLIOGRAPHY


COMPANIES COVERED:

  1. Abbott Laboratories
  2. Abbott Vascular/Abbott Laboratories
  3. Advanced Vascular Dynamics
  4. Arstasis
  5. B. Braun Melsungen AG
  6. BIOTRONIK SE & Co, KG
  7. C.R. Bard
  8. Cardinal Health
  9. Cardiva Medical
  10. CloSys
  11. Davol/C.R.Bard
  12. Edwards Lifesciences Corporation
  13. Endocor
  14. HemCon Medical Technologies
  15. Maquet Holding/Getinge Group
  16. Marine Polymer Technologies
  17. Merit Medical Systems, Inc.
  18. Morris Innovative
  19. Nobles Medical Technologies II
  20. Pu-Yi Medical Technology
  21. Scion BioMedical
  22. St. Jude Medical, Inc.
  23. Terumo Interventional Systems/Terumo Corporation
  24. TZ Medical
  25. Vascular Solutions, Inc.
  26. Z Medica
Contact Us

Need help finding medtech research? Let us help you!